Healthios is a decade-old FINRA registered boutique investment bank dedicated exclusively to the global healthcare industry. Healthios seeks to be the premier investment bank serving the global healthcare industry by combining global deal experience with differentiated access to capital, resources and ideas that are the foundation of what we believe is superior value.
As a leading healthcare-focused investment bank, Healthios seeks to:
- Distinguish the differentiated needs of the healthcare industry
- Align its interests with those of investors, buyers and growth companies which are its foundations
- Commit world-class resources in support of superior value creation throughout the investment horizon.
Healthios sponsors the industry recognized Healthios Exchange (“H/X”), a unique research platform that enables invited users to access the resources, research and relationships which in our view are fundamental to superior value creation in the healthcare sector. As an extension of H/X, Healthios also sponsors regular partnering events in conjunction with major industry conferences. As an example, the July 2012 American Association for Clinical Chemistry (AACC) partnering event facilitated 247 one-on-one meetings among the 110 attendees (including 55 strategic business development professionals and 28 venture-backed CEOs). Of the $2 billion of venture funding raised by in vitro diagnostics companies in the last three years, $800 million went to the 30 emerging growth companies present, representing 40% of the “smart money” in the sector. Healthios annually hosts similar industry conference events at numerous industry events, including the American Diabetes Association Scientific Sessions – ADA, American College of Clinical Oncology – ASCO, American College of Chest Physicians Annual Meeting – CHEST, North American Spine Society – NASS, and Transcatheter Cardiovascular Therapeutics – TCT, as well as investor events at Deer Valley in March and San Francisco in January 2013.
We believe Healthios holds a distinct global position of being in direct and continuous contact with the vast majority of venture-backed, emerging growth healthcare companies, and as such is ideally situated as a strategic partner and an origination source for Back Bay Group and its affiliates.
